LLY
1,058.87
+1.65%↑
JNJ
203.92
+0.27%↑
ABBV
236.16
+2.85%↑
UNH
319.35
+2.41%↑
AZN
91.01
+2.64%↑
LLY
1,058.87
+1.65%↑
JNJ
203.92
+0.27%↑
ABBV
236.16
+2.85%↑
UNH
319.35
+2.41%↑
AZN
91.01
+2.64%↑
LLY
1,058.87
+1.65%↑
JNJ
203.92
+0.27%↑
ABBV
236.16
+2.85%↑
UNH
319.35
+2.41%↑
AZN
91.01
+2.64%↑
LLY
1,058.87
+1.65%↑
JNJ
203.92
+0.27%↑
ABBV
236.16
+2.85%↑
UNH
319.35
+2.41%↑
AZN
91.01
+2.64%↑
LLY
1,058.87
+1.65%↑
JNJ
203.92
+0.27%↑
ABBV
236.16
+2.85%↑
UNH
319.35
+2.41%↑
AZN
91.01
+2.64%↑
24h
Current
Min
8.62
Max
8.86
Recommendations | Strong Buy |
|---|---|
12 Months Forecast | +156.19% upside |
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
27 lis 2024, 13:34 UTC
CervoMed Shares Rise 15% on FDA's Orphan Drug Designation for Neflamapimod
DJ
Read
Price change
By TipRanks
12 Months Forecast
Average 22.75 USD 156.19%
High 27 USD
Low 19 USD
Based on 4 Wall Street analysts offering 12 month price targets forCervoMed Inc - Dist in the last 3 months.
By TipRanks
Strong Buy
4 ratings
4
Buy
0
Hold
0
Sell
Based on 4 analysts giving stock ratings to CervoMed Inc - Dist in the past 3 months.
$